 Hi guys, how you doing? This is Rich here and we have a Rich TV Live and I'm here with a very special guest. It's Jason. So how you doing today? I'm good. How you doing? Very good. And we're here to talk about Stilkana Inc. So why don't we just get started? How why don't you tell us a little bit about Stilkana Inc. Stilkana. Well, Stilkana has only been Stilkana really for the last four months. And what we are and what we're trying to do is become a leader in the bulk sale of CBD isolate in Europe and the world. Not only sale but obviously manufacturers. So we've got the hemp fields in Poland and we'll have two extraction facilities online in Europe for the fourth quarter of this year. And why the focus on the European markets? Well, there's a number of reasons. One is very big. The last estimate for 2021, I believe was 66 billion. It's also 28 separate countries that we can freely move our hemp related products across borders. And I guess the third reason is that, you know, we're one of the leaders in the space because we were there before everybody started talking about CBD. CBD is quite new. A lot of people and a lot of companies are jumping into it headlong right now. But my farmers have been farming in Poland for the last 20 years. In fact, their parents were farming hemp even prior to that. So really comes down to experience. Also, CBD has been legally available on the shelves in Europe for the last five years. Whereas the US just came online now. Canada, you still really can't buy CBD related products yet. You can go get high and smoke a joint. So, you know, Europe is a great spot because they're used to it. They know it and they know how to grow it. And that was where our opportunity laid. That's great. And can you elaborate on your partnership with Dragonfly Biosciences LLC? Yes. So Dragonfly is a leader in CBD products in Europe. They're on the shelves of boots. They just signed a deal with Harrods. They have an 85% footprint on the shelves in London. So there are, you know, you can't walk very far on London without finding Dragonfly products. How the relationship started was that just over, I guess, almost a year ago, I had visited their fields in Bulgaria, which were 100% grown organically. It was very impressed with the team and they needed help with the financing of their extraction facility in Romania. And so still kind of stepped up and we brought our technology and our team and our money to build up that extraction facility to extract their CBD for them. This plant, I was just there, it's incredible. It's built to GMP standards. And we should be processing their first batch of CBD out of Romania for the fourth quarter of this year. We'll have a film coming out in the next 10 days where I've done a walk-through and a tour with the local mayor and showed him the facility and we're very excited to get started. Wow, it seems like you guys are doing a lot of work. Now, are there any other future... Oh, there's one more thing I should add. Go ahead. Sorry. Go ahead. This is very, very important. So Dragonfly are not only our partners in the facility. They own 51% we own 49. But what's really great about this deal was that it gets us straight into revenue. So we've got a contract that can bring up to $40 million Canadian over the next three years of processing exclusively all of their CBD for their acreages in Bulgaria. Wow, that's impressive. Had to get that out there. Sorry. No, it's good. It's good. We want to know everything. Get it all out there. Is there any other future partnerships that you're working on in the pipeline? We have a number of different partnerships. We've brought on Warren Robinson onto our board and it's his job to follow up on conversations that I have with a bunch of different companies and M&A opportunities or a number of different exploratory conversations. Nothing, of course, that's material that we can announce. We'll make sure we, when we do, we announce it. We have Mark Criminie, who is our head of sales. And he's currently negotiating a number of large isolate sales deals. Currently, we have our first deal is with biosciences out of Los Angeles. And they're buying up to $6 million worth of isolate from us starting in the fourth quarter of this year from Poland. Wow. You guys have a lot of business going on. We do. Now, before I get into the next question, one of the things that we talked about is that you guys have the potential to be one of the only companies in the sector to be revenue positive. Yeah. I mean, that was always my goal against the cannabis only four months old. It really a year. You know, the original vehicle that I came onto as CEO, the goal was to try to find a company in this space. And the second goal was to get to revenue as soon as possible and to get to cash flow positive revenue as soon as possible. I really want to kind of break those records. And I know it's really important to investors, especially now. They're seeing a lot of companies in the cannabis space. I want to make sure that, you know, everyone knows we're not in the cannabis space. We're only in CBD, but, you know, we sort of get painted with that brush. And so a lot of the companies that come up with these tremendous forecasts that unfortunately haven't met those. And so what I want to do is be one of the companies in that grouping that hits revenue and record time. And I believe if we can hit our revenue targets in the fourth quarter of this year, we will break records. Wow, that's incredible. And I'm sure you guys will. It's looking really good. I mean, you know, if I look at it from a risk perspective, it's okay, where can these guys go wrong? So if we take it from the step of farming, while they have farming experts that have been farming this land in Poland for 20 years, and their family have been farming for 20 years prior to that, and they've never ever lost a crop. Wow, that's impressive. And I was just there and they've had record temperatures this year. Obviously, climate change has played a huge part in that, or the reason for it. And they've been able to increase their yield. So when I was there two weeks ago, the plants were up to my knees and they're going to be harvesting now two and a half weeks from today. So we have the farming down. I feel very comfortable there. You take it to the next step where you have extraction and my team has been extracting in Canada now for the last five years and they've brought over a thousand batches. And now we've built that same system on a much larger scale in Europe and we're about to turn on the lights in the quarter. So if we end, we've now got the sales contract. So we have all the pieces in place to definitely have revenues in the fourth quarter. That is incredible. Now, earlier last month, you announced an LOI with Sequoia Cannabis in anticipation of a bumper crop yield in Poland this year. We'd love to know more about your plans for this anticipated yield. Okay, so I have to be careful about talking exactly about how much yield in this sort of thing and forecasting numbers until we start to generate revenues. But what I can tell you is again, because the temperatures have been a lot warmer in Europe and especially in Poland, our yield is going to be larger this year than we expected. So we're going to have extra biomass available. And again, speaking to my earlier point of wanting to hit revenues as soon as possible and be cash flow positive, we were reached out to by another processor and they were interested in buying some of our biomass to process. And so we had extra biomass that I know I wasn't going to be able to produce this year. So we're going to sell up the extra biomass. So it was a little bit of icing on the cake this year. Oh, that's nice. Now, you guys also did a $24 million raise. What expansion plans do you have in the horizon with that $24 million that you raise in financing? Well, the $24 million, you know, and it was great because we got some excellent institutional investors in that round, which I'm very excited about. And I'm working with strategically for different objectives and potentials in the future. But with this $24 million, what it allowed us to do was to pick up the Allamax acquisition to buy their seeds, which they're one of only four companies in the EU that have their own registered high concentration CBD seed, which is very, very important. Yes. And they had over 40 tons of seeds ready for us to plant this year to go 1500 hectares in Poland, which will make us the largest hemp farmers in all of Poland this year. So that money allowed us to buy that company, to buy the seeds, to buy the planting equipment, now to buy the harvesting equipment and to build our second extraction facility in Poland. So we've just named them in a press release we put out today. So the JV with Dragonfly in Romania, which is really just a tolling station for us is named the origin. And the second facility, which we're building right now in Poland is called the Nexus. And the third will be a larger facility that takes both the technology and what we've learned in Romania and in Poland to build an even larger extraction facility that will be over twice the output of both of the first two facilities called the horizon. So the money's allowed us to do all of that. And so we're it's a busier. Yeah, you guys seem like you're crazy busy. Now, you touched on the press release, maybe now's a good time to talk about it. Do you want to maybe go over the press release that you announced today? Yeah, I mean, the press release, when I was over in Poland a couple of weeks ago, I went to go meet with the farmers and tour our different plots just to see how the plants were doing. I brought a film crew with me to to film and to interview these ladies. And it's really a generational story what we have in Poland. So you can imagine, you know, the two ladies of all the max who we acquired. As I said earlier, they've been they've been farming and harvesting hemp and making products in the CBD space for CBD products for five years and they're farming for for 20 years. Christina has a son and her son is Matias. And so Matias grew up with her with his grandfather in the fields and now with his mother in the fields. And now he's a Stokana employee and he's been brought on to manage harvesting and build out of both the Nexus facility and the Horizon facility in Poland. And it's really a great story. And you'll see if you see the YouTube video produced, you'll be able to see his story and his mother's story. And he's worked for a very large harvesting company that is focused on how to properly harvest CBD. A lot of people, you know, it's like any new industry you learn as you make mistakes. Yes. And, you know, all the max has made these mistakes and they've learned how to harvest and they've also learned how to drive the material because CBD is quite delicate. And depending on how you harvest it and how you dry it and how you store it, you're going to have CBD degradation. And what Matias has done for all the max and what he's going to do now for Stokana is to manage that process. And so we're very lucky to have him on board. He sends me pictures daily. Currently the Nexus facility, the floor has been laid and they're putting up the structure now. And so we're hoping to get the facility up and running a little bit sooner than the fourth quarter. But we're thinking, you know, I'm pushing it hard. Hey guys, how you doing here with Jason? And one of the questions that our members were asking was what catalysts are there that investors could look forward to over the next little bit for Stokana? Is there any catalysts that we can kind of look forward to? I mean, there's going to be a lot of catalysts. I think the biggest catalyst is going to be revenue, you know, and that's what we're striving for. We will be generating revenue the moment that our extraction facilities are up and running. We have two contracts, one with Dragonfly Biosciences and then of course the one with Biosciences out of Los Angeles. So as soon as those facilities are up and running, we'll be generating revenue. With Romania, I can tell you that everything is ready to go and ready to turn on and that we're just going through final permitting process. So the permitting process to build a facility like this is quite onerous and there's a lot of different stages that you need to meet. But we do expect that we'll meet all of those, you know, we're at the final yard line. Now we're getting into operational permits. So we've got all the permits that you need in order to, you know, produce CBD. Now we're just dealing with like the operational permits. So by the fourth quarter of this year, I mean really it's going to be about bringing in revenues and that's going to be the major catalyst. Because, you know, again, we have all the pieces, a very exciting story, but people want to see where are your revenues. So I think that's your biggest catalyst. I agree. How about your share structure? Is there anything that you want to talk about like as far as your share structure? Like every company share structure is different. Some plan to have a lot held by management so that there's not this huge overhang out there in the market, like a huge flow. Some like to issue some to some large institutions to get involved. Is there anything you want to talk about with your share structure? Because I know it's pretty small share structure. Yeah, it's a small share structure. You know, we do have a number of warrants out there that are in the money. And so we've been, you know, it's a good and bad thing because you've got, of course, 50 cent warrants. People are double their investment right now. And so but that's good because it brings more money. So we've got 4 million that we expect to come in over the next year, which is great. And what we tried to do with this latest financing was put it into some institutional hands. And there's a number of very important funds that have invested in us in this last round. And that's the future is to try to get, you know, those groups getting more involved in the market and taking out a lot of retail shareholders because, you know, this is always sort of where we're at right now is you've got a lot of retail shareholders that are involved and a retail shareholder will get emotionally involved. And so when they see the stock price ticked down a little bit, they get worried and they think, okay, there must be something wrong with the company. Whereas an institutional investor looks at a little bit more long term. So we're trying to transition. And you know, last time I was in London a couple of weeks ago, I was dealing with a couple of larger funds there. They've introduced me to some groups that will be starting to do some institutional roadshows. And and yeah, so, you know, it's the retail shareholders have been great and they've really, really helped us out a lot and we want them involved. But I think, you know, looking to more institutional money gives you a little bit more stability. Absolutely. Because if, you know, one retail shareholder that has some 25 cent stock from our last round, again, we've only been around for four months, you know, this is a very new company. So when we first started and did our first raise of 25 cents, you know, those shares can be generated if somebody decides to sell, you know, 200,000 shares in a day, it can actually hurt your stock. Of course. And so that will change as we get more awareness out there and as we grow as a company and as we meet our revenue targets, you're going to see a lot more stability in the market and we look forward to that. Great. I have a really good question. Oh, actually, I'll bring up one of the questions here. Will Still Canada, this is from Joshua. Thank you, Josh, for your question. Will Still Canada be selling product to North America, South America and Australia? Well, that's a great question. So, you know, one of the, one of our first sales contract out of Poland is with Biosciences. And of course, you know, as they're a private labeler and they're going to be buying our Islet, it would certainly make sense for us in the future to, you know, it's a very easily deal to get done, right? Yes. And therefore, if we have our products formulated, we just give them our formulations, we give them our Islet or our oil and our labels and they can distribute. So I think the US is a very easy deal to get done. It's something that we've looked at. It's something that we're exploring and it's something we're going to do. But again, you know, our main focus right now needs to be fulfilling the contracts that we have in place because we can fill the contracts we have in place on the large Islet sales, then we're a profitable company. So that's where we want to focus. Now, on the brand side, there is higher margins, of course, and it's something that we're developing with the doctor and we will, you know, reach that market as far as Australia. We don't, I don't have any connections there. No one on the Boardhouse Connections there. I'm sure it's a fantastic market and if somebody wants to reach out that has distribution on Australia and fulfillment, we'd love to hear from them. And what was the third country to mention? South America. South America. Again, the same as Australia. We don't have any contacts there yet or right now or wide open to it. But, you know, I think as far as a retail brand goes, Europe would be first. I think US shortly after that. And then, you know, we'll see about other countries or other comments. Okay, great. This is another question about still Canada's thoughts about an effort of entering into the US market. It seems as though our members have an affinity to the US market. Is that something that is like part of your guys mandate? I mean, obviously America is 10 times the size of Canada. Yeah. So there's a huge opportunity there. We have all the ingredients to make it happen, right? I mean, we have the package or in fact, we even have the distributor. And once we've developed the brand, it's a very easy thing for us to accomplish. So absolutely for sure. We just want to make sure again, you know, that 90% is focused on the sales we already have in the door on the box side. But 10% of our time, we are working on developing a line. And the US makes a lot of sense. And it's we have all the ingredients in order to move that forward. Very good. I have a question, one of the things I've noticed with companies as they move along with achieving their goals is they try to move to a senior exchange, whether it be the TSX or the NASDAQ in your stock exchange. We've seen this with a lot of companies. Is that something that you guys are looking to do in the future? Are you looking to move to a bigger exchange? I think it makes more sense. Yeah. I mean, that's the idea is as you grow, you can get onto exchanges. And as you move up, there's less impediments for investors to get involved. So for sure, once we've reached our targets, I think the logical move would be obviously to the venture up to the if we can, you know, we would meet the requirements will go as high as we can go. And then of course, do a list on the NASDAQ. We are looking at potentially listening in London. We've met with a group in London and a couple of the funds that are there believe that this is a story as its European would really speak to the European investors and to the UK investors. I mean, they can go on the shelves at their local drug store and buy Dragonfly products right off the shelf. So fantastic company that's going to be putting, you know, the CBD in those bottles form would make sense to be on exchange over that. So we're looking at that as well. Another question I have actually is and I mean, you're an expert at this. So I want to ask you, why can't why is Health Canada not legalizing CBDs? Do you have any insight on what like legalizing their legalizing edibles? Yeah, October 17. They legalized cannabis last year, October 17. But why CBDs? No, I don't understand. Do you have any insight on that? Is CBD is very new, you know, a lot of people on the inside known about CBD for quite some time. But when I was talking about CBD two years ago, the investment community did not care. I mean, you know, it was all about, you know, first it was, you know, your LPs, your licensed producers in Canada and then that had a huge run and then you had, you know, your multi-state operators in the US and different brands and then that had a huge run. And so now all of a sudden the investment community and the people, the drivers behind that sort of community are now looking to what's next. And so CBD was something that was sort of bubbling up a little bit when we had the fortune to get financed and move forward. But, you know, governments and they take a little bit of time to catch up on new things. So they're going to try to figure out what, you know, what is this? What is CBD? And of course, because, you know, CBD as far as a lot of people think, and it's not me, but a lot of people believe that there's a lot of health benefits with it. I actually do believe it personally, but, you know, as a company in this space, you can't say that it has any health benefits to it. Of course. But, you know, there's no doubt that the people want it. And I think the government's going to have to figure out what it is and how they're going to push it. So what Canada is doing, you know, is maybe they're protecting their LPs, right? Because these LPs took a lot of money out of the market and they've really, the government, I think, would like these companies to succeed. So I think a lot of the licensing will go under the existing LPs and there'll be a lot of new companies that are coming in through this. It'd be interesting to see how it goes. I think we'll learn a lot about October. We'll learn a lot more in October when they come out with sort of the Edibles plan. So, you know, we'll see. Canada is a beautiful place and, you know, we would love to have an extraction facility here and get involved. But I would like to sort of see, you know, what the structure is going to be before we do that. And I think that, you know, potentially still kind of partnering up with a company that has maybe the growing or the acreage and that maybe we would build the extraction facility could be a very interesting fit for Canada. Yeah, I think that that would be fantastic. I would love to see it personally because I do take CBDs and I feel like there are health benefits. I mean, I hear it every single day. There's so many stories and I mean every single day, you know, talking to cab people in cabs, talking to people in the street, when I was raising money, I would go into my first few meetings and I would talk about the CBD thing and then find out that half the people in the room were on it and the other half had a friend that was honored or their parents were on it or somebody was taking it and everybody had told me that they have, that they see these benefits. So I think there's, you know, there's certainly something to it and the people certainly want it and the governments will catch up. And I mean, I think CBD should be read as readily available as vitamin C. That's great. I have another question here from Joshua. Are you in a rush? No. Okay. Perfect. Is there a common CBD industry standard metric for cost per unit CBD? And if so, what is still can as number in comparison to other CBD producers? Example, marijuana producers have a cost program. Yes. Okay. So good question, Josh. Thank you. Yeah. Our cost program is estimated around 50 to 80 cents per gram. Now, we're able to produce it for less for a number of reasons. One main reason is that we're working, you know, our facility in Romania is this tiny little village called Lista. In fact, we'll be either the first or second largest employer of this small area and, you know, a lot of companies that are in our space will know this that if you're looking for sort of a PhD that knows anything about extracting, you're going to be paying this person a minimum of $300,000 a year. Wow. I can tell you that our PhD is a lot less than that. I can also tell you that our workers with forklifts and this sort of thing are, you know, the cost of living in Romania in this little village is quite low. So I like that our production costs are definitely on below side. So, yeah, I mean, what the rest of the industry is paying right now, again, it's really new. I can tell you that there's companies right now that are paying 11 euros per gram. Wow. Just to extract. Wow. Okay. So you're doing it for 50 to 80 cents. Yeah. So, but that's and again, that's the big difference just now and then then you take in the prices of Iceland prices at 33, you know, 380 US per gram. It doesn't make sense. So, you know, we've scoured Europe looking for an extraction company that could do what we can do. I haven't found one, so it's very difficult to really give you that pricing. What I can tell you is that I do know a company that does extracting. It was the lowest price that we could find in Europe and it was 11 euros per gram. Wow, that's so and we're estimated. Yeah, that's like what 20 to 80 cents. Yeah. Yeah. Yeah. It doesn't even make sense. It doesn't make financial sense. Absolutely. So I hope that answers the question. Yeah. No, that's very good. Another question. Cannabis is, thank you, Danny Boy for this. Cannabis is a volatile market. Thus, investors are reluctant to invest with companies under a dollar. What still can is view in obtaining investor interest? Yeah, I mean, that's why I'm here, right? I mean, the idea is to just get the story out. And I think the best way to get the story out is through videos. And so that's why we are doing this and that's why we set up a YouTube channel under StillCanna, which shows behind the scenes look of what we're doing. So our first video was with our doctor. The next video was in Poland, which we're setting up today. I don't think it's up yet, but it's coming. And then the following one will be in Romania and just showing people where the investors' dollars are going. And then, of course, we've got different, as many different outreaches as we possibly can to get the story out. Also meeting with, I was in London at a trade show called Cannabis Europa. And while I was there, I was meeting with all the different funds and really just getting out there and telling your story. Obviously, a big one will be analyst coverage and we are working towards getting analyst coverage at the stage that we're at right now. And as new as we are, it takes time. Of course, it's only a lot of people else, right? Yeah, it's only four months. And so I think we've been able to do some tremendous things in a very short period of time. And I think you need to, when you're looking at companies like this, look into, really dig into all the details. And I know that the deeper that you dig into still Canada, the more opportunity that you'll see. I have a question. One thing I've noticed lately is that Kronos Group came out and said that Health Canada is making it very difficult for these Canadian LPs. Before that, Vivo Cannabis came out and said that Health Canada is making it very difficult for Canadian LPs. Now, what do you think about that? Well, because, I mean, as an investor, I kind of agree with them, but as a person who's focused on health, I got children, I kind of agree with what Health Canada is doing. I mean, they're trying to make sure it's done right. Right? Yeah, I mean, I mean, they're rolling out slowly. Yeah, for me, I don't use cannabis. I'm not a proponent of it. I think that it kills brain cells. And I don't think it's really a great thing. I also don't think, you know, alcohol is a really great thing. I, what gets me off is, you know, trying to live as long as I can live a healthy life and try to build business and enjoy myself in the process. And, you know, hopefully building a successful company. So cannabis doesn't really jive with what I'm into. But for sure, if this is something that people are ingesting and something that they enjoy, but I'm also libertarian. So I think that every drug should be legal, you know, I mean, but in regulated in this way that, you know, you are getting the safest product possible. So yeah, let him regulate it and, you know, you know, if it slows down the process, but, you know, saves people any negative complications, then great. Fantastic. And I got one more question for you. I don't see any other questions from the group here and I know you probably got a run soon. So last question, Bruce Linton has publicly stated that Canada is a waste of time. Okay. What do you think about that comment? Well, I understand where he's coming from, right? I mean, you're looking at Canada's what just over 30 million people and you look at the other populations around the world, just look at our neighbors in the U.S. It's 300 million, you know, somebody quite famous who's a very successful business person. You may know Gene Simmons. You may know him. Oh, yes. And so Gene's a friend of mine. We've had a lot of multiple business ventures in the past and when he saw what I was doing in Canada at the time, which is a fashion line, he said, what do you bother wasting your time up there? He goes, you can become the biggest in Canada. What does that mean worldwide? Nothing. So he became the biggest in the U.S. and the rest of the world is listening. And it's true, you know, so it's kind of true that way. You know, Canada will always follow whatever is happening in the U.S. And the U.S. is very open to, you know, look at any sort of Canadian superstars and businessmen. They've really made it outside of Canada in most scenarios and then Canada will come on. So that's why I think it's really important for us to have our U.S. listening and we do spend a lot of time on marketing to the U.S. because you're dealing with, you know, a lot more people and it's really a percentage thing. So I don't think Canada's waste of time. I just think that if you're going to market in Canada and you're going to focus in Canada, it's a much smaller segment than if you were to focus in Europe, which is 28 countries or you're focused in the U.S., which is, you know, over 300 million people. So yeah, I mean, it's a great country. But if you make it in the U.S., Canada will follow. If you make it into Canada, will the U.S. necessarily follow? Not necessarily. Not necessarily. I think in the cannabis side, that's maybe the only time it's kind of true because we came out with legalization on a large scale. So there's a lot of excitement about that. And, you know, what Canada does have going forward is an investment community. They're really good at start-ups. You know, I mean, Canada has been fantastic with us and I think, you know, the largest financiers in the world when it comes to cannabis. Oh yeah. And they're really good at, you know, getting things started. But I think once you've got those started, then you definitely have to, you know, market in the U.S. Absolutely. Market in Europe. Oh, that's great. Well, thank you so much, Jason, for being here today with us. Yeah, thanks for having me. I wish you the best of luck in our community to be watching very closely. And what we're going to do is we're going to continue with this live stream and we're going to show you some more information on Still Canada. And we'll continue to watch your story. And if there's anything else that you have that is newsworthy, we'd love to be able to cover it. And who knows, maybe one day you'll see RichTVLive in Poland or Romania. I think I would love to have you. Yeah, I would love to go down there. So maybe we can talk about that too in the future. And if you have any other videos that are worthwhile, we'd love to be able to show it to our community and continue to tell your story. So thank you very much for being here today. I wish you the best of luck. Great, thank you. This is Jason Dussault, the CEO of Still Canada. Thanks, Jason. So we're going to continue with this live stream and we're going to show you a little bit more information on Still Canada. I believe we have a video that we're going to show now. Is that correct? Is it a video we're going to show now? Perfect. So I think we're going to be able to put a video here behind us. Hope you guys are having a good day today. Danny Boy's question is, there's an ocean of cannabis companies. What sets Still Canada's products above the rest? That's a very good question, Danny Boy. What we're going to do is we're going to pull up some information here. We're going to show you a little video and hopefully that answers your questions. If you guys have any other questions for me personally, feel free to drop it in the live chat. We'll just continue with this live stream and we're just going to continue to tell you the story. You want me to pull it up? Okay. So how do I pull it up on here? Oh, with here. It's actually going through my email. It's got to be a better way to do it. If you go into YouTube. Let's go to YouTube. All right. Still Canada. Let's scroll down. This one right here. It's like you're going to the channel. Here we go. This one right here. Perfect. In this year, we've decided that for 2019, we're going to produce around 16 tons of CBD. For the next year, we're planning to increase this production. We think that in a very short time, it will turn out that our possibilities are very high. I'm Olga. I'm the owner of the company. I'm the owner of the company, Onimax. We grew up together with Krysten. It was a tradition. It was a tradition of our family. My family and my friends were very close friends. It's a very special tradition. It's a tradition of our children. As a child, I remember me, my mom, and my grandfather working on the potential tent. I always wanted to do the same as they did. Now we are going to build a tent for the CBD, for the technology, for the harnessing and the extraction. We're going to grow 1500 hectares. We're going to process about 500 tons of harvest per day. That means every year, we can grow 15 kilos of CBD. My grandfather will be proud of me. Onimax is going to be the biggest grower and producer of CBD info. Our partnership with Onimax brings farmers that have been farming camp on land just like this one over the last 20 years and experiences in something that you can buy. We're very excited to be working with Onimax. It's really the perfect partnership with the farmers who haven't lost their crops in years and an extraction team that has extracted over 5,000 batches of CBD over the last five years. We're going to work very well here, with our farmers. The production process, the farming process, the growing of the fodder, the farming, and the sowing. Everything is doing differently for us than the time it takes. We're very proud of this partnership. This year, together with the farmers, That video looks so impressive and it's exciting to see what still Cannes is doing and to be able to actually sit down with Jason. Hi, my name is Nate, owner of Grover's House, one of the top suppliers of cultivation equipment in the world. Grover's House. So many cannabis people in the game. So yeah, so just looking into this and doing my research on still Cannes, I'm going to continue to learn more about still Cannes, I'm going to continue to bring you guys more. That's our modus operandi here at Rich TV Live is to bring you guys good quality content, interview CEOs and tell the story. I spoke to Jason about going to facilities and really getting to know this company and hopefully we'll be able to do that moving forward. If you guys have any other questions or concerns or if there's anything you'd like to know, please put the comments in the comments of this video. If you liked the video, smash the like button, share the video everywhere and remember, if I win and you win, we all win. So at this point in time, what I'm going to do is I'm going to wish you all the best of luck. Thank you for joining us today. Thank you for being here today and I'm going to go and do more research and more due diligence on still Cannes myself. I don't currently think that this is a company that has a great future. And after speaking to Jason and getting a better idea of what the company is all about, I think it's a company that we have to keep on our watch list. We need to keep on our radar and I think it has the potential to be a major player in the CBD space. Thank you guys for watching. Thank you guys for being here and if you're not winning, you're not watching. This is Rich from Rich TV Live. I'm signing out. Have a nice day.